BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33347474)

  • 1. Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines.
    Ajibola G; Bennett K; Powis KM; Hughes MD; Leidner J; Kgole S; Batlang O; Mmalane M; Makhema J; Lockman S; Shapiro R
    PLoS One; 2020; 15(12):e0244100. PubMed ID: 33347474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of pneumococcal antibodies among HIV-exposed, uninfected infants in Botswana.
    Uffman EA; Li SH; Chen JL; Allen N; Boiditswe S; Fouda GG; Hurst JH; Patel MZ; Steenhoff AP; Cunningham CK; Qin E; Davenport CA; Kelly MS
    Vaccine; 2022 Aug; 40(33):4764-4771. PubMed ID: 35773120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect Effects of 10-Valent Pneumococcal Conjugate Vaccine Against Adult Pneumococcal Pneumonia in Rural Western Kenya.
    Bigogo GM; Audi A; Auko J; Aol GO; Ochieng BJ; Odiembo H; Odoyo A; Widdowson MA; Onyango C; Borgdorff MW; Feikin DR; Carvalho MDG; Whitney CG; Verani JR
    Clin Infect Dis; 2019 Nov; 69(12):2177-2184. PubMed ID: 30785189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Haemophilus influenzae Type b and 13-Valent Pneumococcal Conjugate Vaccines on Childhood Pneumonia Hospitalizations and Deaths in Botswana.
    Congdon M; Hong H; Young RR; Cunningham CK; Enane LA; Arscott-Mills T; Banda FM; Chise M; Motlhatlhedi K; Feemster K; Patel SM; Boiditswe S; Leburu T; Shah SS; Steenhoff AP; Kelly MS
    Clin Infect Dis; 2021 Jul; 73(2):e410-e416. PubMed ID: 32634831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV.
    Nunes MC; Cutland CL; Klugman KP; Madhi SA
    mBio; 2021 Jan; 12(1):. PubMed ID: 33419872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pneumococcal conjugate vaccine on community-acquired pneumonia hospitalizations in children with comorbidity.
    Sterky E; Bennet R; Lindstrand A; Eriksson M; Nilsson A
    Eur J Pediatr; 2017 Mar; 176(3):337-342. PubMed ID: 28070670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.
    Simonsen L; Taylor RJ; Young-Xu Y; Haber M; May L; Klugman KP
    mBio; 2011 Jan; 2(1):e00309-10. PubMed ID: 21264063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa.
    Groome MJ; Zell ER; Solomon F; Nzenze S; Parashar UD; Izu A; Madhi SA
    Clin Infect Dis; 2016 May; 62 Suppl 2():S188-95. PubMed ID: 27059355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    de Sévaux JL; Venekamp RP; Lutje V; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD001480. PubMed ID: 33231293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study.
    Binks MJ; Beissbarth J; Oguoma VM; Pizzutto SJ; Leach AJ; Smith-Vaughan HC; McHugh L; Andrews RM; Webby R; Morris PS; Chang AB
    Lancet Child Adolesc Health; 2020 Jun; 4(6):425-434. PubMed ID: 32450122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.
    Fathima P; Gidding HF; McIntyre PB; Snelling TL; McCallum L; de Klerk N; Blyth CC; Liu B; Moore HC
    Lancet Child Adolesc Health; 2019 Oct; 3(10):713-724. PubMed ID: 31439496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua.
    Becker-Dreps S; Amaya E; Liu L; Moreno G; Rocha J; Briceño R; Alemán J; Hudgens MG; Woods CW; Weber DJ
    Pediatr Infect Dis J; 2014 Jun; 33(6):637-42. PubMed ID: 24445827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status.
    Madhi SA; Koen A; Jose L; van Niekerk N; Adrian PV; Cutland C; François N; Ruiz-Guiñazú J; Yarzabal JP; Moreira M; Borys D; Schuerman L
    Medicine (Baltimore); 2017 Jan; 96(2):e5881. PubMed ID: 28079828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
    Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
    Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience.
    Madhi SA; Nunes MC
    Hum Vaccin Immunother; 2016; 12(2):314-25. PubMed ID: 26317537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
    Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
    BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Declines in Vaccine Type Pneumococcal Carriage in Children Less Than 5 Years Old After Introduction of 10-valent Pneumococcal Conjugate Vaccine in Mozambique.
    Sigaúque B; Moiane B; Massora S; Pimenta F; Verani JR; Mucavele H; Chaúque A; Quintó L; Dos Santos RT; Carvalho MDG; Whitney CG; Lessa FC
    Pediatr Infect Dis J; 2018 Oct; 37(10):1054-1060. PubMed ID: 30216295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001480. PubMed ID: 31135969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting.
    Johnstone SL; Moore DP; Klugman KP; Madhi SA; Groome MJ
    Paediatr Int Child Health; 2020 Feb; 40(1):50-57. PubMed ID: 31156062
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
    Clarke E; Bashorun A; Adigweme I; Badjie Hydara M; Umesi A; Futa A; Ochoge M; Obayemi D; Edem B; Saidy-Jah E; Onwuchekwa C; Dhere R; Sethna V; Kampmann B; Goldblatt D; Taylor D; Andi-Lolo I; Hosken N; Antony K; Innis BL; Alderson MR; Lamola S
    Lancet Infect Dis; 2021 Jun; 21(6):834-846. PubMed ID: 33516293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.